zacopride has been researched along with reboxetine in 1 studies
Studies (zacopride) | Trials (zacopride) | Recent Studies (post-2010) (zacopride) | Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) |
---|---|---|---|---|---|
180 | 4 | 16 | 626 | 193 | 184 |
Protein | Taxonomy | zacopride (IC50) | reboxetine (IC50) |
---|---|---|---|
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.0018 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castro, E; Pazos, A; Valdizan, EM; Vidal, R; VilarĂ³, MT | 1 |
1 other study(ies) available for zacopride and reboxetine
Article | Year |
---|---|
Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats.
Topics: Action Potentials; Adenylyl Cyclases; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Benzamides; Brain; Bridged Bicyclo Compounds, Heterocyclic; CA1 Region, Hippocampal; Cyclohexanols; Drug Interactions; Male; Morpholines; Pyramidal Cells; Radioligand Assay; Rats; Rats, Wistar; Reboxetine; Receptors, Serotonin, 5-HT4; Signal Transduction; Venlafaxine Hydrochloride | 2010 |